6Hicks RJ, Kalff V, MacManus MP, et al.18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med, 2001,42: 1596～604.
7Erdi YE, Macapinlac H, Rosenzweig KE, et al. Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med, 2000, 27:861 ～6.
8Coleman RE. PET in lung cancer. J Nucl Med, 1999, 40: 814-20.
9Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA, 2001,21,285: 914～24.
10Yap CS, Seltzer MA, Schiepers C, et al. Impact of whole-body 18F FDG PET on staging and managing patients with breast cancer: the referring physician' s perspective. J Nucl Med,2001,42: 1334～7.
